new_0222_0694|GRCL|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0694|GRCL|Long Name|1|1|Gracell Biotechnologies Inc Total Current Assets (Quarterly) (USD)|Gracell Biotechnologies Inc Cash and Short Term Investments (Quarterly) (USD)|Gracell Biotechnologies Inc Inventories (Quarterly) (USD)|Gracell Biotechnologies Inc Net PP&E (Quarterly) (USD)|Gracell Biotechnologies Inc Goodwill and Intangibles (Quarterly) (USD)|Gracell Biotechnologies Inc Total Liabilities (Quarterly) (USD)|Gracell Biotechnologies Inc Total Current Liabilities (Quarterly) (USD)|Gracell Biotechnologies Inc Total Long Term Liabilities (Quarterly) (USD)|Gracell Biotechnologies Inc Total Deposits (Quarterly) (USD)|Gracell Biotechnologies Inc Book Value (Quarterly) (USD)|Gracell Biotechnologies Inc Retained Earnings (Quarterly) (USD)|Gracell Biotechnologies Inc Treasury Stock (Quarterly) (USD)|Gracell Biotechnologies Inc EV to Revenues|Gracell Biotechnologies Inc EV to Earnings|Gracell Biotechnologies Inc EV to Free Cash Flow|Gracell Biotechnologies Inc EV to Assets (Quarterly)|Gracell Biotechnologies Inc PS Ratio|Gracell Biotechnologies Inc PE Ratio|Gracell Biotechnologies Inc Price to Book Value|Gracell Biotechnologies Inc PEG Ratio|Gracell Biotechnologies Inc Debt to Equity Ratio|Gracell Biotechnologies Inc Dividend Yield|Gracell Biotechnologies Inc Shareholder Yield (TTM)|Gracell Biotechnologies Inc Percent of Shares Outstanding Short|Gracell Biotechnologies Inc Total Receivables (Quarterly) (USD)|Gracell Biotechnologies Inc Total Payables (Quarterly) (USD)|Gracell Biotechnologies Inc Total Capital Stock (Quarterly) (USD)|Gracell Biotechnologies Inc Return on Invested Capital|Gracell Biotechnologies Inc Quality Ratio Score|Gracell Biotechnologies Inc Momentum Score|Gracell Biotechnologies Inc Beta (1Y)|Gracell Biotechnologies Inc Sustainable Growth Rate (TTM)|Gracell Biotechnologies Inc Institutional Investor Ownership Percentage|Gracell Biotechnologies Inc Average Diluted Shares Outstanding (Quarterly)|Gracell Biotechnologies Inc Total Employees (Annual)|Gracell Biotechnologies Inc EPS Diluted (Quarterly) (USD)|Gracell Biotechnologies Inc Shares Outstanding|Gracell Biotechnologies Inc Repurchase of Capital Stock (Quarterly) (USD)|Gracell Biotechnologies Inc Ordinary Shares Number (Quarterly)|Gracell Biotechnologies Inc Payout Ratio|Gracell Biotechnologies Inc Quick Ratio (Quarterly)|Gracell Biotechnologies Inc Normalized Diluted EPS (Quarterly) (USD)|Gracell Biotechnologies Inc Stock Buybacks (Quarterly) (USD)|Gracell Biotechnologies Inc Effective Tax Rate (TTM)|Gracell Biotechnologies Inc Return on Equity|Gracell Biotechnologies Inc Net Income (TTM) (USD)|Gracell Biotechnologies Inc Revenue (TTM) (USD)|Gracell Biotechnologies Inc Dividend Per Share (Quarterly) (USD)|Gracell Biotechnologies Inc Revenue (Quarterly) (USD)|Gracell Biotechnologies Inc Gross Profit (Quarterly) (USD)|Gracell Biotechnologies Inc SG&A Expense (Quarterly) (USD)|Gracell Biotechnologies Inc Pre-Tax Income (Quarterly) (USD)|Gracell Biotechnologies Inc Net Income (Quarterly) (USD)|Gracell Biotechnologies Inc Net Interest Income (Quarterly) (USD)|Gracell Biotechnologies Inc Price (USD)|Gracell Biotechnologies Inc Total Return Price (USD)|Gracell Biotechnologies Inc Enterprise Value (USD)|Gracell Biotechnologies Inc 30-Day Average Daily Volume|Gracell Biotechnologies Inc 1 Year Price Returns (Daily)
new_0222_0694|GRCL|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0694|GRCL||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0694|GRCL||5|5|127.8|127.8|0|127.8|0|127.8|127.8|127.8|0|127.8|127.8|0|0|0|0|0|0|0|1.44|0|0|1.44642857143|0|15.24|183|183|127.8|0|0|0|0|0|0|91.2857142857|92|91.2857142857|53.4|366|127.8|0|0|91.2857142857|0|91.25|0|91.25|0|0|0|0|91.2857142857|91.2857142857|91.2857142857|91.2857142857|1.44483985765|1.44483985765|1.44642857143|1.43426294821|1.40740740741
new_0222_0694|GRCL||6|6|5|5|0|5|0|5|5|5|0|5|5|0|0|0|0|0|0|0|225|0|0|280|0|25|2|2|5|0|0|0|0|0|0|7|1|7|5|1|5|0|0|7|0|4|0|4|0|0|0|0|7|7|7|7|281|281|280|251|27
new_0222_0694|GRCL||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0694|GRCL|201909|201909|201909||||||||||||||||||||||||||||||||||||||-6.3716|||||||||||||||||||||
new_0222_0694|GRCL|201912|201912|201912|48.6439|45.2002||10.2709||22.4189|2.5963|19.8226||-41.8028|-41.3611||||||||||||||1.968|0.9604|78.3085|||||||19.809||-0.3829|||327.816|||-0.3098|||||||||1.1251|-6.0767|-6.0767|0.2041|||||
new_0222_0694|GRCL|202003|202003|202003||||||||||||||||||||||||||||||||||19.809||-0.3087||||||-0.2316|||||||||0.8057|-4.5768|-4.5768|0.1371|||||
new_0222_0694|GRCL|202006|202006|202006||||||||||||||||||||||||||||||||||19.809||-0.4492||||||-0.3252|||||||||0.9832|-6.4567|-6.4567|0.0723|||||
new_0222_0694|GRCL|202009|202009|202009|31.5976|25.9988||18.2985||11.2545|4.7159|6.5386||38.6416|-67.9843||||||||||||||3.8942|0.0507|0.0211|||||||65.5632|160|-0.1518||0|327.816|||-0.1065||0||-24.4135|||||1.182|-7.3033|-7.3033|-0.0583|||||
new_0222_0694|GRCL|202012|202012|202012|124.8173|118.3247||22.8799||22.2379|14.29|7.9479||-89.981|-86.3314||||||||||||||4.739|1.855|215.4507|||||||65.5632|202|-0.2299|||327.816|||-0.1907||0||-30.9442|||||3.738|-12.6074|-12.6074|-0.0529|||||
new_0222_0694|GRCL|202101|202012|202012||||||||||||||||||||||0||0.6694|||||||||||||65.5632||||||||||||||||||20.72|20.72|1471.333||
new_0222_0694|GRCL|202102|202012|202012||||||||||||||||||||||0||0.9158|||||||||||||||||||||||||||||||22.73|22.73|1603.115|169109.3333|
new_0222_0694|GRCL|202103|202103|202103|337.9449|329.6041||21.8489||29.4168|18.3866|11.0303||333.4007|-100.8334||||||||3.1046|||0||1.1446|||0.0337|||||||60.8977||-0.2543|67.2132||336.066|||-0.2536||0||-41.42|||||4.8949|-15.0526|-15.0526|-0.0467|15.4|15.4|722.6154|78132.6|
new_0222_0694|GRCL|202104|202103|202103|||||||||||||||||||2.4555|||0||0.5839|||||||||||||||||||||||||||||||12.18|12.18|506.1889|101217.1333|
new_0222_0694|GRCL|202105|202103|202103|||||||||||||||||||3.0361|||0||1.0414|||||||||||||||||||||||||||||||15.06|15.06|699.7629|119358.4667|
new_0222_0694|GRCL|202106|202106|202106|327.3844|317.6493||25.0079||33.8597|20.3969|13.4628||320.6256|-117.5394||||||||2.7264|||0||1.7698|||0.0343|||||||67.2334||-0.2244|67.2435||336.2175|||-0.2226||0||-49.8552|||||4.7086|-14.8919|-14.8919|0.0498|13|13|574.1051|185401.9|
new_0222_0694|GRCL|202107|202106|202106|||||||||||||||||||2.6069|||0||1.8462|||||||||||||||||||||||||||||||12.43|12.43|535.7763|136908.4667|
new_0222_0694|GRCL|202108|202106|202106|||||||||||||||||||2.1874|||0||1.7826|||||||||||||||||||||||||||||||10.43|10.43|401.2893|88771.9667|
new_0222_0694|GRCL|202109|202109|202109|311.8934|302.4784||24.1289||34.1746|21.2134|12.9612||305.2839|-137.3981|||||1.9187|||3.0667||0.0576|0||1.6233|||0.0345|||||||67.2989||-0.2934|67.4994||337.4969||14.2588|-0.2915||0||-62.5151|||0.0565||6.6183|-19.9632|-19.9632|0.2928|13.87|13.87|651.3095|57506.3|
new_0222_0694|GRCL|202110|202109|202109|||||||||||||||||||2.3658|||0||0.9395|||||||||||||||||||||||||||||||10.7|10.7|437.3364|105176.8333|
new_0222_0694|GRCL|202111|202109|202109|||||||||||||||||||1.7113|||0||1.7056|||||||||||||||||||||||||||||||7.74|7.74|237.5381|910152.5667|
new_0222_0694|GRCL|202112|202112|202112|||||||||||||||||||1.3355|||0||1.9722|||||||||||||||||||||||||||||||6.04|6.04|122.7892|1023034.1333|
new_0222_0694|GRCL|202201|202112|202112|||||||||||||||||||0.7849|||0||1.5374|||||||||||||||||||||||||||||||3.55|3.55|-45.2843|260251.3667|-82.8668
new_0222_0694|GRCL|202202|202112|202112|||||||||||||||||||0.7473|||0|||||||||||||||||||||||||||||||||3.38|3.38|-44.6093|330261.4667|-86.8828